Medicare Enrolled
Dr. Alpana Desai, M.D.
Medical Oncology · Stuart, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Alpana Desai is a medical oncology in Stuart, FL, with 19 years in practice. Based on federal Medicare data, Dr. Desai performed 296,968 Medicare services across 5,291 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desai received a total of $24,334 from 99 pharmaceutical and/or device companies across 1423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 5% volume in FL$ $24,334 industry payments
Medicare Practice Summary
Medicare Utilization ↗296,968
Medicare services
Top 5% in FL for medical oncology
5,291
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~15,630 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 96,900 | $0 | $4 |
| Iron sucrose injection (Venofer) | 36,000 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 28,200 | $43 | $137 |
| Injection, mepolizumab, 1 mg | 23,500 | $23 | $72 |
| Filgrastim injection (Zarxio) for white blood cells | 22,380 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 18,420 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 15,050 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 13,650 | $1 | $5 |
| Immune globulin infusion (Gammagard) | 12,850 | $36 | $108 |
| Complete blood count (CBC) with differential | 4,431 | $8 | $29 |
| Blood draw (venipuncture) | 4,344 | $8 | $9 |
| Dexamethasone injection (steroid) | 3,634 | $0 | $3 |
| Office visit, established patient (30-39 min) | 2,999 | $98 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 1,992 | $0 | $9 |
| Drug injection, under skin or into muscle | 1,958 | $11 | $69 |
| Injection, benralizumab, 1 mg | 1,740 | $133 | $426 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,440 | $1 | $28 |
| Administration of chemotherapy into vein, 1 hour or less | 750 | $104 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 724 | $50 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 712 | $23 | $84 |
| Injection of additional new drug or substance into vein | 578 | $12 | $61 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 545 | $1 | $6 |
| Injection, diphenhydramine hcl, up to 50 mg | 474 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 384 | $16 | $56 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 325 | $57 | $206 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 268 | $3 | $11 |
| Administration of chemotherapy into vein, each additional hour | 261 | $23 | $79 |
| Injection, carboplatin, 50 mg | 258 | $2 | $41 |
| Office visit, established patient (20-29 min) | 242 | $66 | $239 |
| New patient office visit, complex (60-74 min) | 183 | $172 | $585 |
| Injection, zoledronic acid, 1 mg | 177 | $7 | $69 |
| Infusion into a vein for hydration, each additional hour | 173 | $10 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 148 | $52 | $178 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 137 | $25 | $89 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 130 | $17 | $59 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 130 | $137 | $562 |
| Automated urinalysis | 126 | $2 | $8 |
| Red blood count automated, with additional calculations | 104 | $5 | $20 |
| Prothrombin time test (blood clotting) | 92 | $4 | $15 |
| Infusion, normal saline solution , 1000 cc | 84 | $2 | $7 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 82 | $4 | $15 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 77 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 51 | $16 | $56 |
| Injection of drug or substance into vein | 50 | $30 | $156 |
| Drawing of blood for a medical problem | 49 | $70 | $277 |
| Infusion into a vein for hydration, 31-60 minutes | 44 | $25 | $156 |
| Initial hospital admission, high complexity | 36 | $138 | $556 |
| Office visit, established patient, complex (40-54 min) | 29 | $140 | $474 |
| Red blood count, automated test | 24 | $4 | $10 |
| Hospital follow-up visit, moderate complexity | 19 | $58 | $197 |
| New patient office visit (45-59 min) | 14 | $117 | $453 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.7% high complexity
57.9% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,334
Total received (2018-2024)
Avg $3,476/year across 7 years
Top 21% in FL for medical oncology
99
Companies
1,423
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,251 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,116
2023$4,135
2022$3,575
2021$2,577
2020$2,276
2019$3,742
2018$3,913
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,822
Celgene Corporation
$1,640
Novartis Pharmaceuticals Corporation
$1,578
E.R. Squibb & Sons, L.L.C.
$1,571
PFIZER INC.
$1,507
AstraZeneca Pharmaceuticals LP
$1,342
Incyte Corporation
$1,209
Amgen Inc.
$1,096
GENZYME CORPORATION
$968
Seagen Inc.
$820
GlaxoSmithKline, LLC.
$707
Merck Sharp & Dohme Corporation
$583
Bayer HealthCare Pharmaceuticals Inc.
$473
Astellas Pharma US Inc
$457
Takeda Pharmaceuticals U.S.A., Inc.
$436
Daiichi Sankyo Inc.
$421
Merck Sharp & Dohme LLC
$374
Gilead Sciences, Inc.
$373
Genentech USA, Inc.
$358
Taiho Oncology, Inc.
$340
Pharmacyclics LLC, An AbbVie Company
$326
Ipsen Biopharmaceuticals, Inc
$312
Lilly USA, LLC
$299
EISAI INC.
$225
Dova Pharmaceuticals
$224
Puma Biotechnology, Inc.
$215
JAZZ PHARMACEUTICALS INC.
$208
NanoString Technologies, Inc.
$201
Exelixis Inc.
$188
ABBVIE INC.
$147
Regeneron Healthcare Solutions, Inc.
$146
Karyopharm Therapeutics Inc.
$140
Clovis Oncology, Inc.
$134
Heron Therapeutics, Inc.
$129
BeiGene USA, Inc.
$127
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
Eisai Inc.
$113
Kyowa Kirin, Inc.
$113
PharmaEssentia USA Corporation
$111
Bayer Healthcare Pharmaceuticals Inc.
$109
Janssen Scientific Affairs, LLC
$108
Foundation Medicine, Inc.
$106
Seattle Genetics, Inc.
$105
Sobi, Inc
$103
PUMA BIOTECHNOLOGY, INC.
$101
Pharmacyclics LLC, an AbbVie Company
$98
AbbVie Inc.
$93
MEDIVATION FIELD SOLUTIONS LLC
$88
Mirati Therapeutics, Inc.
$86
Pharmacosmos Therapeutics Inc.
$86
Myriad Genetic Laboratories, Inc.
$80
EMD Serono, Inc.
$70
TerSera Therapeutics LLC
$67
ARRAY BIOPHARMA INC
$66
ADC Therapeutics America, Inc.
$65
SERVIER PHARMACEUTICALS LLC
$65
Kite Pharma, Inc.
$63
TESARO, Inc.
$61
Aveo Pharmaceuticals, Inc.
$53
Shire North American Group Inc
$53
AVEO Pharmaceuticals, Inc.
$52
SOBI, INC
$51
Sirtex Medical Inc
$49
Fennec Pharmaceuticals, Inc.
$44
Aurobindo Pharma USA, Inc.
$44
Lexicon Pharmaceuticals, Inc.
$42
RECORDATI_RARE_DISEASES_INC.
$41
G1 Therapeutics, Inc.
$41
AbbVie, Inc.
$40
ImmunoGen, Inc.
$38
Advanced Accelerator Applications
$35
TAIHO ONCOLOGY, INC.
$35
Dendreon Pharmaceuticals LLC
$32
Secura Bio, Inc.
$30
INSYS Therapeutics Inc
$30
Alexion Pharmaceuticals, Inc.
$28
Deciphera Pharmaceuticals Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
Napo Pharmaceuticals Inc
$26
Legend Biotech USA Inc.
$26
Lundbeck LLC
$24
Biocon Biologics Inc
$21
Partner Therapeutics, Inc.
$20
Array BioPharma Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
Spectrum Pharmaceuticals Inc.
$18
Jazz Pharmaceuticals Inc.
$18
EUSA Pharma (US) LLC
$17
ARGENX US, INC.
$17
Fortovia Therapeutics, Inc.
$17
Tempus AI, Inc
$17
CTI BioPharma Corp.
$16
Adaptive Biotechnologies Corporation
$16
Stemline Therapeutics Inc.
$16
Global Blood Therapeutics, Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$14
SECURA BIO, INC.
$13
Helsinn Therapeutics (U.S.), Inc.
$13
Veracyte, Inc.
$6
Top 3 companies account for 20.7% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BEVESPI AEROSPHERE · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · FASENRA · FASLODEX · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Farydak · Folotyn · GAMMAGARD · GAZYVA · GELCLAIR CONCENTRATED ORAL GEL · GILOTRIF · GIVLAARI · HYQVIA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Pedmark · Phesgo · Pomalyst · Poteligeo · PreciseTumor · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · STELARA · SUSTOL · SUTENT · SYLVANT · SYNDROS · Soltamox · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VYEPTI · VYVGART · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
4
Per 100K population
2.5
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Desai is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Desai performed 96,900 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $24,334 from 99 companies across 1,423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other medical oncologys in Stuart?
Dr. Desai's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Stuart
Browse medical oncologys in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology